Cardiopulmonary function and autologous bone marrow transplantation: results and predictive value for respiratory failure and mortality; The University of Nebraska Medical Center Bone Marrow Trans- plantation Pulmonary Study Group. Bone Marrow Transplant

Respir Dis 1992; 146:485–491 7 Griese M, Rampf U, Hofmann D, et al. Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 2000; 30:393–401 8 Oshima Y, Takahashi S, Nagayama H, et al. Fatal GVHD demonstrating an involvement of respiratory muscle following donor leukocyte transfusion (DLT). Bone Marrow Transplant 1997; 19:737–740 9 Bolwell BJ. Are predictive factors clinically useful in bone marrow transplantation? Bone Marrow Transplant 2003; 32: 853–861 10 Bearman SI, Petersen FB, Schor RA, et al. Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant 1990; 5:173–177 11 Fujimaki K, Maruta A, Yoshida M, et al. Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant 2001; 27:307–310 12 Hertenstein B, Stefanic M, Schmeiser T, et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 1994; 12:998–1004 13 Jain B, Floreani AA, Anderson JR, et al. Cardiopulmonary function and autologous bone marrow transplantation: results and predictive value for respiratory failure and mortality; The University of Nebraska Medical Center Bone Marrow Transplantation Pulmonary Study Group. Bone Marrow Transplant 1996; 17:561–568 14 Zangari M, Henzlova MJ, Ahmad S, et al. Predictive value of left ventricular ejection fraction in stem cell transplantation. Bone Marrow Transplant 1999; 23:917–920 15 Carlson K, Backlund L, Smedmyr B, et al. Pulmonary function and complications subsequent to autologous bone marrow transplantation. Bone Marrow Transplant 1994; 14: 805–811 16 Clark JG, Schwartz DA, Flournoy N, et al. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987; 107:648–656 17 Crawford SW, Fisher L. Predictive value of pulmonary function tests before marrow transplantation. Chest 1992; 101:1257–1264 18 Goldberg SL, Klumpp TR, Magdalinski AJ, et al. Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients. J Clin Oncol 1998; 16:3796–3802 19 Horak DA, Schmidt GM, Zaia JA, et al. Pretransplant pulmonary function predicts cytomegalovirus-associated interstitial pneumonia following bone marrow transplantation. Chest 1992; 102:1484–1490 20 Krowka MJ, Staats BA, Hoagland HC. A prospective study of airway reactivity before bone marrow transplantation. Mayo Clin Proc 1990; 65:5–12 21 Badier M, Guillot C, Delpierre S, et al. Pulmonary function changes 100 days and one year after bone marrow transplantation. Bone Marrow Transplant 1993; 12:457–461 22 Milburn HJ, Prentice HG, du Bois RM. Can lung function measurements be used to predict which patients will be at risk of developing interstitial pneumonitis after bone marrow transplantation? Thorax 1992; 47:421–425 23 Lund MB, Kongerud J, Brinch L, et al. Decreased lung function in one year survivors of allogeneic bone marrow transplantation conditioned with high-dose busulphan and cyclophosphamide. Eur Respir J 1995; 8:1269–1274 24 Keime-Guibert F, Napolitano M, Delattre JY. Neurological complications of radiotherapy and chemotherapy. J Neurol 1998; 245:695–708 25 Couriel DR, Beguelin GZ, Giralt S, et al. Chronic graftversus-host disease manifesting as polymyositis: an uncommon presentation. Bone Marrow Transplant 2002; 30:543– 546 26 Parker P, Chao NJ, Ben Ezra J, et al. Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine (Baltimore) 1996; 75:279–285 27 Dureuil B, Matuszczak Y. Alteration in nutritional status and diaphragm muscle function. Reprod Nutr Dev 1998; 38:175–180 28 van Balkom RH, van der Heijden HF, van Herwaarden CL, et al. Corticosteroid-induced myopathy of the respiratory muscles. Neth J Med 1994; 45:114–122 29 Rochester DF. Respiratory muscles and ventilatory failure: 1993 perspective. Am J Med Sci 1993; 305:394–402 30 Stephenson AL, Mackenzie IR, Levy RD, et al. Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness. Thorax 2001; 56:82–84